Cellular and Molecular Mechanisms of Atherosclerosis with Mouse Models
- 31 July 2004
- journal article
- review article
- Published by Elsevier BV in Trends in Cardiovascular Medicine
- Vol. 14 (5), 187-190
- https://doi.org/10.1016/j.tcm.2004.04.002
Abstract
No abstract availableKeywords
This publication has 42 references indexed in Scilit:
- Diabetes and atherogenesisHeart, 2004
- Specific abrogation of transforming growth factor-β signaling in T cells alters atherosclerotic lesion size and composition in miceBlood, 2003
- Leukotriene B4 Receptor Antagonism Reduces Monocytic Foam Cells in MiceArteriosclerosis, Thrombosis, and Vascular Biology, 2002
- Angiotensin II promotes atherosclerotic lesions and aneurysms in apolipoprotein E–deficient miceJCI Insight, 2000
- Monocyte Chemoattractant Protein-1 Accelerates Atherosclerosis in Apolipoprotein E-Deficient MiceArteriosclerosis, Thrombosis, and Vascular Biology, 1999
- Absence of CC chemokine receptor-2 reduces atherosclerosis in apolipoprotein E-deficient miceAtherosclerosis, 1999
- The effects of total lymphocyte deficiency on the extent of atherosclerosis in apolipoprotein E-/- mice.JCI Insight, 1997
- IFN-gamma potentiates atherosclerosis in ApoE knock-out mice.JCI Insight, 1997
- Immune-deficient mice develop typical atherosclerotic fatty streaks when fed an atherogenic diet.JCI Insight, 1994
- Role of Cytokines in Inducing HyperlipidemiaDiabetes, 1992